Document Detail


Role of gamma-linolenic acid in counteracting doxorubicin-induced damage in cultured rat cardiomyocytes.
MedLine Citation:
PMID:  11334548     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The clinical usefulness of doxorubicin is limited by cardiotoxicity. We have demonstrated that doxorubicin has a dual negative effect on myocardial lipids, acting against highly unsaturated fatty acids (HUFAs) directly and desaturating/elongating enzymes required for their biosynthesis, thus decreasing linoleic and alpha -linolenic conversion to higher metabolites. Primary cultures of rat cardiomyocytes were challenged with different doxorubicin concentrations and doxorubicin exposure was followed by a 24-h recovery period in the absence or presence of serum, and of gamma -linolenic acid. Serum in the recovery medium did not appear to be essential for the restoration of the desaturating/elongating activities, and gamma -linolenic acid supplementation influenced only alpha -linolenic acid conversion. Serum, and particularly gamma-linolenic acid, were very important in increasing HUFA levels behind the pure biosynthesis. HUFA biosynthesis plays a role in counteracting doxorubicin toxicity, but it cannot completely overcome the depletion of these fatty acids; serum and exogenous gamma-linolenate are critical in filling the decreased HUFA pool.
Authors:
S Hrelia; A Bordoni; P L Biagi
Related Documents :
19058788 - Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relati...
11463268 - Phosphinic acid pseudopeptides analogous to glutamyl-gamma-glutamate: synthesis and cou...
3864158 - Photoaffinity labeling of diphtheria toxin fragment a with nad: structure of the photop...
8039478 - Tiagabine: a novel drug with a gabaergic mechanism of action.
12523388 - Metabolic engineering of glutamate production.
19058788 - Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relati...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Prostaglandins, leukotrienes, and essential fatty acids     Volume:  64     ISSN:  0952-3278     ISO Abbreviation:  Prostaglandins Leukot. Essent. Fatty Acids     Publication Date:  2001 Mar 
Date Detail:
Created Date:  2001-05-03     Completed Date:  2001-07-26     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8802730     Medline TA:  Prostaglandins Leukot Essent Fatty Acids     Country:  Scotland    
Other Details:
Languages:  eng     Pagination:  139-45     Citation Subset:  IM    
Copyright Information:
Copyright 2001 Harcourt Publishers Ltd.
Affiliation:
Dipartimento di Biochimica G. Moruzzi, University of Bologna, Bologna, Italy. hrelia@biocfarm.unibo.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents / adverse effects,  pharmacology
Cells, Cultured
Dose-Response Relationship, Drug
Doxorubicin / adverse effects,  pharmacology*
Fatty Acids, Unsaturated / metabolism
Myocardium / cytology*,  metabolism
Rats
Rats, Wistar
Time Factors
alpha-Linolenic Acid / metabolism
gamma-Linolenic Acid / physiology*
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Fatty Acids, Unsaturated; 23214-92-8/Doxorubicin; 463-40-1/alpha-Linolenic Acid; 506-26-3/gamma-Linolenic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Using CCM for the Prediction of Sorption Curves under Varying Ionic Strength Conditions: Reply to So...
Next Document:  Modulation of intestinal vitamin D receptor availability and calcium ATPase activity by essential fa...